TrialDiabetes, obesity & metabolism2016

Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.

H W Rodbard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.